Related Experiment Video
Updated: Aug 15, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk
R K Ganju1, S A Brubaker, R D Chernock
1Division of Experimental Medicine, Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA. rganju@caregroup.harvard.edu
Abstract:
The beta-chemokine receptor CCR5 has been shown to modulate cell migration, proliferation, and immune functions and to serve as a co-receptor for the human immunodeficiency virus. We and others have shown that CCR5 activates related adhesion focal tyrosine kinase (RAFTK)/Pyk2/CAK-beta. In this study, we further characterize the signaling molecules activated by CCR5 upon binding to its cognate ligand, macrophage inflammatory protein-1beta (MIP1beta). We observed enhanced tyrosine phosphorylation of the phosphatases SHP1 and SHP2 upon MIP1beta stimulation of CCR5 L1.2 transfectants and T-cells derived from peripheral blood mononuclear cells. Furthermore, we observed that SHP1 associated with RAFTK. However, using a dominant-negative phosphatase-binding mutant of RAFTK (RAFTK(m906)), we found that RAFTK does not mediate SHP1 or SHP2 phosphorylation. SHP1 and SHP2 also associated with the adaptor protein Grb2 and the Src-related kinase Syk. Pretreatment of CCR5 L1.2 transfectants or T-cells with the phosphatase inhibitor orthovanadate markedly abolished MIP1beta-induced chemotaxis. Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation. Taken together, these results suggest that MIP1beta stimulation mediated by CCR5 induces the formation of a signaling complex consisting of RAFTK, Syk, SHP1, and Grb2.
Insights
The beta-chemokine receptor CCR5, a target for HIV, activates signaling pathways involving RAFTK and Syk kinases. This study identifies a signaling complex including RAFTK, Syk, SHP1, and Grb2, crucial for MIP1beta-induced cell migration.
Area of Science:
- Immunology
- Cell Biology
- Molecular Signaling
Background:
- The beta-chemokine receptor CCR5 plays a role in cell migration, proliferation, and immune responses.
- CCR5 also functions as a co-receptor for the human immunodeficiency virus (HIV).
- Previous research indicated CCR5 activates related adhesion focal tyrosine kinase (RAFTK)/Pyk2/CAK-beta.
Purpose of the Study:
- To further characterize signaling molecules activated by CCR5 upon binding to its ligand, macrophage inflammatory protein-1beta (MIP1beta).
- To elucidate the roles of phosphatases SHP1 and SHP2, and the kinase Syk in CCR5-mediated signaling.
- To determine the upstream or downstream relationship between RAFTK and Syk in this pathway.
Main Methods:
- Stimulation of CCR5-expressing cells (L1.2 transfectants and T-cells) with MIP1beta.
- Analysis of tyrosine phosphorylation of SHP1 and SHP2.
- Co-immunoprecipitation assays to study protein-protein interactions (SHP1-RAFTK, SHP1/SHP2-Grb2-Syk, Syk-RAFTK).
- Use of dominant-negative mutants of RAFTK (RAFTK(m906), RAFTK(m402)) and phosphatase inhibitor (orthovanadate).
- Assessment of MIP1beta-induced chemotaxis.
Main Results:
- MIP1beta stimulation enhanced tyrosine phosphorylation of SHP1 and SHP2 in CCR5-expressing cells.
- SHP1 associated with RAFTK, but RAFTK did not mediate SHP1/SHP2 phosphorylation.
- SHP1 and SHP2 associated with Grb2 and Syk; Syk was activated by MIP1beta and associated with RAFTK.
- Dominant-negative RAFTK mutants attenuated Syk activation, while wild-type RAFTK enhanced it, indicating RAFTK acts upstream of Syk.
- Orthovanadate pretreatment abolished MIP1beta-induced chemotaxis.
Conclusions:
- MIP1beta stimulation of CCR5 leads to the activation of phosphatases SHP1 and SHP2.
- The signaling pathway involves the formation of a complex including RAFTK, Syk, SHP1, and Grb2.
- RAFTK acts upstream of CCR5-mediated Syk activation, playing a key role in MIP1beta-induced cell migration.
More Related Videos
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
09:40Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway